Literature DB >> 24478560

PCT as a Prognostic Marker in Cardiac Patients with Neutropenic Sepsis: Two Case Reports.

Neelima Verma1, Shaloo Kapoor2, Deepa Rao2, Siddhartha Sharma2, Anita Arora2.   

Abstract

Procalcitonin (PCT) is an innovative and highly specific marker for diagnosis of clinically relevant bacterial infection and sepsis. PCT supports early diagnosis and Clinical decision making. A retrospective study of two classical cases of neutropenic sepsis with elevated PCT levels in cardiac ICU was done. PCT was analyzed using Elecsys Brahms PCT kit. Serum PCT levels <0.5 ng/ml and ANC <1,000/mm(3) was taken as cutoff. The first patient had initial high levels of PCT 100 ng/ml, TLC 13,600/mm(3) and ANC 12,250/mm(3). It was followed by drop with subsequent rise in PCT levels and drop in TLC 1,000/mm(3) and ANC 70/mm(3). The second patient had normal PCT 0.116 ng/ml, TLC 5,600/mm(3) and ANC 4,420/mm(3) levels followed with sharp increase in all the values with subsequent drop in TLC 2,000/mm(3) and ANC 880 cells/mm(3). Both the patients died of neutropenic sepsis with multiorgan failure. The case reports showed the correlation of PCT with TLC and ANC levels in predicting the mortality of patients with neutropenic sepsis in cardiac ICU.

Entities:  

Keywords:  Absolute eosinophil count; Cardiac patients; Neutropenic sepsis; Procalcitonin; Total leucocyte count

Year:  2013        PMID: 24478560      PMCID: PMC3903924          DOI: 10.1007/s12291-013-0382-4

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  18 in total

1.  Procalcitonin increase in early identification of critically ill patients at high risk of mortality.

Authors:  Jens Ulrik Jensen; Lars Heslet; Tom Hartvig Jensen; Kurt Espersen; Peter Steffensen; Michael Tvede
Journal:  Crit Care Med       Date:  2006-10       Impact factor: 7.598

2.  Association of serum procalcitonin with cardiovascular prognosis in coronary artery disease.

Authors:  Christoph R Sinning; Jan-Malte Sinning; Andreas Schulz; Renate B Schnabel; Edith Lubos; Philipp S Wild; Jana Papassotiriou; Andreas Bergmann; Stefan Blankenberg; Thomas Munzel; Christoph Bickel
Journal:  Circ J       Date:  2011-03-03       Impact factor: 2.993

3.  Procalcitonin expression in human peripheral blood mononuclear cells and its modulation by lipopolysaccharides and sepsis-related cytokines in vitro.

Authors:  M Oberhoffer; I Stonans; S Russwurm; E Stonane; H Vogelsang; U Junker; L Jäger; K Reinhart
Journal:  J Lab Clin Med       Date:  1999-07

4.  Procalcitonin in patients with and without immunosuppression and sepsis.

Authors:  B al-Nawas; P M Shah
Journal:  Infection       Date:  1996 Nov-Dec       Impact factor: 3.553

5.  Procalcitonin, C-reactive protein, white blood cells and SOFA score in ICU: diagnosis and monitoring of sepsis.

Authors:  G P Castelli; C Pognani; M Cita; A Stuani; L Sgarbi; R Paladini
Journal:  Minerva Anestesiol       Date:  2006 Jan-Feb       Impact factor: 3.051

6.  Postoperative plasma concentrations of procalcitonin after different types of surgery.

Authors:  M Meisner; K Tschaikowsky; A Hutzler; C Schick; J Schüttler
Journal:  Intensive Care Med       Date:  1998-07       Impact factor: 17.440

7.  Immunosuppression in sepsis.

Authors:  Peter A Ward
Journal:  JAMA       Date:  2011-12-21       Impact factor: 157.335

8.  Monitoring procalcitonin in febrile neutropenia: what is its utility for initial diagnosis of infection and reassessment in persistent fever?

Authors:  James Owen Robinson; Frédéric Lamoth; Frank Bally; Marlies Knaup; Thierry Calandra; Oscar Marchetti
Journal:  PLoS One       Date:  2011-04-25       Impact factor: 3.240

9.  Diagnostic accuracy of procalcitonin in critically ill immunocompromised patients.

Authors:  Nicolas Bele; Michael Darmon; Isaline Coquet; Jean-Paul Feugeas; Stéphane Legriel; Nadir Adaoui; Benoît Schlemmer; Elie Azoulay
Journal:  BMC Infect Dis       Date:  2011-08-24       Impact factor: 3.090

10.  Procalcitonin (PCT) and C-reactive protein (CRP) as severe systemic infection markers in febrile neutropenic adults.

Authors:  Karin S R Massaro; Silvia F Costa; Claudio Leone; Dalton A F Chamone
Journal:  BMC Infect Dis       Date:  2007-11-22       Impact factor: 3.090

View more
  3 in total

1.  Prognostic value of CD4(+)CD25(+) Tregs as a valuable biomarker for patients with sepsis in ICU.

Authors:  Kun Chen; Qiu-Xiang Zhou; Hong-Wei Shan; Wen-Fang Li; Zhao-Fen Lin
Journal:  World J Emerg Med       Date:  2015

2.  Serum sTREM-1, PCT, CRP, Lac as Biomarkers for Death Risk Within 28 Days in Patients with Severe Sepsis.

Authors:  Lefeng Zhang; Xiaohong Zhang
Journal:  Open Life Sci       Date:  2018-04-06       Impact factor: 0.938

3.  Procalcitonin as a Biomarker for Malignant Cerebral Edema in Massive Cerebral Infarction.

Authors:  Yan Zhang; Gang Liu; Yuan Wang; Yingying Su; Rehana K Leak; Guodong Cao
Journal:  Sci Rep       Date:  2018-01-17       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.